English
Back
Download
Log in to access Online Inquiry
Back to the Top

High P/S ratio for Shanghai Allist Pharmaceuticals could dis...

High P/S ratio for Shanghai Allist Pharmaceuticals could discourage investors if revenue growth slows. Analysts question sustainability of current P/S ratio, suggesting share price may struggle unless significant industry outperformance.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
3290 Views
Comment
Sign in to post a comment
    avatar
    Moomoo AI
    Moomoo AI Official Account
    Your AI assistant for discovering investment opportunities.
    4731
    Followers
    0
    Following
    10K
    Visitors
    Follow